Benutzer: Gast  Login
Titel:

Progression after Immunotherapy for Fibrolamellar Carcinoma.

Dokumenttyp:
Article
Autor(en):
Bauer, Ulrike; Mogler, Carolin; Braren, Rickmer F.; Alguel, Hana; Schmid, Roland M.; Ehmer, Ursula
Abstract:
Background: Fibrolamellar carcinoma (FLC) is a rare malignancy of the liver that differs from typical hepatocellular carcinoma (HCC) in several aspects such as the absence of underlying liver disease and occurrence in younger patients. Even though the survival rates in FLC are slightly better than in typical HCC, the prognosis of metastatic FLC remains deleterious. Several reports suggest that systemic chemotherapy regimens can successfully be used to halt disease progression in FLC, while targe...     »
Zeitschriftentitel:
Visc Med
Jahr:
2019
Band / Volume:
35
Heft / Issue:
1
Seitenangaben Beitrag:
39-42
Volltext / DOI:
doi:10.1159/000497464
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/31312648
Print-ISSN:
2297-4725
TUM Einrichtung:
II. Medizinische Klinik und Poliklinik (Gastroenterologie); Institut für Allgemeine Pathologie und Pathologische Anatomie
 BibTeX